Literature DB >> 17447093

Comment on: Should we really worry about "launch delays" of new drugs in OECD countries? by L. Garatinni and S. Ghislandi.

Joshua Cohen1.   

Abstract

Mesh：

Year:  2007        PMID： 17447093     DOI： 10.1007/s10198-007-0055-4

Source DB:  PubMed          Journal:  Eur J Health Econ        ISSN： 1618-7598


× No keyword cloud information.
  4 in total

1.  Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis.

Authors:  Nancy Devlin; David Parkin
Journal:  Health Econ       Date:  2004-05       Impact factor: 3.046

2.  The impact of price regulation on the launch delay of new drugs--evidence from twenty-five major markets in the 1990s.

Authors:  Patricia M Danzon; Y Richard Wang; Liang Wang
Journal:  Health Econ       Date:  2005-03       Impact factor: 3.046

3.  Should we really worry about "launch delays" of new drugs in OECD countries?

Authors:  Livio Garattini; Simone Ghislandi
Journal:  Eur J Health Econ       Date:  2007-03

4.  Patient access to pharmaceuticals: an international comparison.

Authors:  Joshua Cohen; Laura Faden; Susan Predaris; Brian Young
Journal:  Eur J Health Econ       Date:  2007-02-06
  4 in total
  1 in total

1.  Assessing the impact of global price interdependencies.

Authors:  Anke Richter
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.